Lantheus Holdings, Inc. reported $1.56B of revenue over the trailing twelve months, +2.3% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.56B (to Q2 2026). Net income: $275M, trailing twelve months to Q2 2026. Free cash flow: $388M, trailing twelve months to Q2 2026. Operating margin: 19%, trailing twelve months to Q2 2026.

LNTHLantheus Holdings, Inc.

Healthcare

$100.15+99% 1Y

$100.15

$50.1152 weeks$109.01

LNTH as reported

Lantheus Holdings, Inc. reported $1.56B of revenue over the trailing twelve months, +2.3% on the year before. 11 reported series are charted on this page, each one as filed.

$1.56B

Revenue, trailing twelve months · to Q2 2026 · +2.3% against the twelve months before

Net income: $275M
Net income · +1.6% year on year · trailing twelve months to Q2 2026
Free cash flow: $388M
Free cash flow · −19% year on year · trailing twelve months to Q2 2026
Operating margin: 19%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for LNTH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.56B	+2.3%	Q2 2026
Net income	$275M	+1.6%	Q2 2026
EPS	$4.13	+10%	Q2 2026
Gross margin	60%	n/a	Q2 2026
Operating margin	19%	n/a	Q2 2026
Net margin	18%	n/a	Q2 2026
ROE	20%	n/a	Q2 2026
ROA	10%	n/a	Q2 2026
ROIC	19%	n/a	Q2 2026
Free cash flow	$388M	−19%	Q2 2026
P/E	24.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.